The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial.

PLoS One. 2018 Mar 15;13(3):e0193846. doi: 10.1371/journal.pone.0193846.

eCollection 2018. PubMed PMID: 29543887; PubMed Central PMCID: PMC5854344.

Iseri K, Iyoda M, Watanabe M, Matsumoto K, Sanada D, Inoue T, Tachibana S, Shibata T.

https://www.ncbi.nlm.nih.gov/pubmed/29543887
Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada